BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Japan’s Daiichi Sankyo Expands Global R&D Footprint with New Research Institute in San Diego

Daiichi Sankyo (TSE: 4568) has established Daiichi Sankyo Research Institute in San Diego, representing the third research institute established outside of...

October 06, 2025 | News

ExQor Technologies Prepares for Clinical Trials of Regenerative Platform Aiming to Reverse Alzheimer’s Damage

ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine pla...

October 06, 2025 | News

HKUST Uncovers Genetic Variant Driving Alzheimer’s Risk Among Ethnic Chinese

A landmark study conducted by The Hong Kong University of Science and Technology (HKUST) has demonstrated that a genetic variant, TREM2 ...

October 06, 2025 | News

Japan Grants National Reimbursement for MedHub-AI AutocathFFR Marking a Breakthrough in AI-Driven Coronary Physiology

MedHub-AI announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's Autoca...

October 06, 2025 | News

Thermo Fisher’s PPD™ Clinical Research Joins AstraZeneca BioVentureHub for R&D Partnership in Sweden

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development ...

October 02, 2025 | News

Made Scientific and Syenex Forge Partnership to Transform T Cell Therapy Manufacturing

Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in ...

October 01, 2025 | News

Full-Life Technologies Secures US$77 Million in Series C and Debt Financing to Advance Global Radiopharmaceutical Pipeline

Series C led by Junson Capital along with new investor syndicate and existing shareholders Funding will further advance Full-Life's global radiopharmace...

September 30, 2025 | News

Takara Bio Europe launches Cellartis® MSC EV Wonder™ to boost scalable, high-quality EV production

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder™, a defined, xeno-free medium engineered for the scalable production of extrac...

September 30, 2025 | News

Catalent Opens New Global Headquarters in Tampa to Shape the Future of Biopharma Innovation

Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New ...

September 29, 2025 | News

ASCP Launches Performance and Diagnostics Insights to Elevate Laboratory Benchmarking and Patient Care

- The American Society for Clinical Pathology (ASCP) has launched Performance and Diagnostics Insights (PDI), a groundbreaking platform designed to transfo...

September 29, 2025 | News

Hengrui Pharma Grants Glenmark Exclusive Global Licence for HER2-Targeted ADC Trastuzumab Rezetecan

Hengrui Pharma, a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced that it has entered ...

September 25, 2025 | News

Lunit and CellCarta Form Global Partnership to Advance AI-Powered Pathology in Clinical Trials

Lunit , a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, announced a strategic partnership with CellCarta, a globa...

September 25, 2025 | News

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Advance AI-Powered Genomic Testing in Breast and Prostate Cancer

SOPHiA GENETICS an AI technology company transforming precision medicine announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq:...

September 23, 2025 | News

Galux Validates AI-Driven Platform with Atomic-Level Precision in De Novo Antibody Design

Study confirms the novelty and atomic-level precision of de novo antibody design, including cryo-EM validation on a designed anti-PD-L1 antibody Finding...

September 23, 2025 | News

Stay Connected